MaxCyte Q4 Core Revenue Expected to Range from $6.6M to $6.7M

lunes, 12 de enero de 2026, 8:18 am ET1 min de lectura
MXCT--

MaxCyte expects Q4 core revenue between $6.6M and $6.7M, and full-year core revenue between $29.5M and $29.6M. The company also mentioned SPL program-related revenue for the fourth quarter.

MaxCyte Q4 Core Revenue Expected to Range from $6.6M to $6.7M

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios